Regulatory Alerts
Keep up-to-date with key announcements and guidance from organisations including NICE, DHSC and MHRA.
SMC accepts treatment for moderate-to-severe atopic dermatitis
Tralokinumab is accepted for restricted use within NHS Scotland.
Keep up-to-date with key announcements and guidance from organisations including NICE, DHSC and MHRA.
